Cargando…
Absence of mgrB Alleviates Negative Growth Effects of Colistin Resistance in Enterobacter cloacae
Colistin is an important last-line antibiotic to treat highly resistant Enterobacter infections. Resistance to colistin has emerged among clinical isolates but has been associated with a significant growth defect. Here, we describe a clinical Enterobacter isolate with a deletion of mgrB, a regulator...
Autores principales: | Wozniak, Jessie E., Chande, Aroon T., Burd, Eileen M., Band, Victor I., Satola, Sarah W., Farley, Monica M., Jacob, Jesse T., Jordan, I. King, Weiss, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699182/ https://www.ncbi.nlm.nih.gov/pubmed/33227907 http://dx.doi.org/10.3390/antibiotics9110825 |
Ejemplares similares
-
MgrB Mutations and Altered Cell Permeability in Colistin Resistance in Klebsiella pneumoniae
por: Yap, Polly Soo-Xi, et al.
Publicado: (2022) -
MgrB Alterations Mediate Colistin Resistance in Klebsiella pneumoniae Isolates from Iran
por: Haeili, Mehri, et al.
Publicado: (2017) -
MgrB-Dependent Colistin Resistance in Klebsiella pneumoniae Is Associated with an Increase in Host-to-Host Transmission
por: Bray, Andrew S., et al.
Publicado: (2022) -
MgrB Inactivation Confers Trimethoprim Resistance in Escherichia coli
por: Shi, Hongmei, et al.
Publicado: (2021) -
Prevalence and epidemiological investigation of mgrB-dependent colistin resistance in extensively drug resistant Klebsiella pneumoniae in Iran
por: Zahedi Bialvaei, Abed, et al.
Publicado: (2023)